Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

1,779 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Clinical pharmacology and pharmacogenetics of thiopurines.
Sahasranaman S, Howard D, Roy S. Sahasranaman S, et al. Among authors: howard d. Eur J Clin Pharmacol. 2008 Aug;64(8):753-67. doi: 10.1007/s00228-008-0478-6. Epub 2008 May 28. Eur J Clin Pharmacol. 2008. PMID: 18506437 Review.
Rebuttal to Mahmood.
Bonate PL, Howard D. Bonate PL, et al. Among authors: howard d. J Clin Pharmacol. 2000 Apr;40(4):345-6. doi: 10.1177/00912700022009035. J Clin Pharmacol. 2000. PMID: 10761160 No abstract available.
Vildagliptin, a novel dipeptidyl peptidase IV inhibitor, has no pharmacokinetic interactions with the antihypertensive agents amlodipine, valsartan, and ramipril in healthy subjects.
He YL, Ligueros-Saylan M, Sunkara G, Sabo R, Zhao C, Wang Y, Campestrini J, Pommier F, Dole K, Marion A, Dole WP, Howard D. He YL, et al. Among authors: howard d. J Clin Pharmacol. 2008 Jan;48(1):85-95. doi: 10.1177/0091270007307880. Epub 2007 Nov 6. J Clin Pharmacol. 2008. PMID: 17986525 Clinical Trial.
1,779 results